Study,Study Country,Study Site,Subject,Event Group Label,Event Group Name,Event Group Sequence Number,Event Label,Event Name,Event Date,Form Casebook Version,Form Label,Form Name,Form Sequence Number,Form Status,Datetime of Form Creation,Form First Submission Date,Form Last Submission Date,Form ILB Status,Form ILB Reason,Item Group Sequence Number,Datetime of Last Data Change,Data Listing As Of,Opened Queries,Closed Queries,Temporary AE serial number (ig_FA_AE_HF.TRIGGER_LINK_ID1),1. AE serial number (ig_FA_AE_HF.FA_LINK_ID1),2. Date of vital signs (ig_FA_AE_HF.VS_DT),2. Date of vital signs (ig_FA_AE_HF.VS_DT)_RAW,3. Systolic blood pressure (ig_FA_AE_HF.VS_BP_SYSTOLIC),4. Diastolic blood pressure (ig_FA_AE_HF.VS_BP_DIASTOLIC),Blood pressure units (ig_FA_AE_HF.VS_BP_U),5. Pulse (ig_FA_AE_HF.VS_PULSE),Pulse units (ig_FA_AE_HF.VS_PULSE_U),6. Respiratory rate (ig_FA_AE_HF.VS_RESP_RATE),Respiratory rate units (ig_FA_AE_HF.VS_RESP_RATE_U),7. Temperature (ig_FA_AE_HF.VS_TEMPERATURE),7. Temperature (ig_FA_AE_HF.VS_TEMPERATURE)_U,7. Temperature (ig_FA_AE_HF.VS_TEMPERATURE)_TRANS,7. Temperature (ig_FA_AE_HF.VS_TEMPERATURE)_TRANSU,Category (ig_FA_AE_HF.QS_CATEGORY),Text (ig_FA_AE_HF.QS_DD_NAME),8. Date of NYHA Score (ig_FA_AE_HF.QS_DT),8. Date of NYHA Score (ig_FA_AE_HF.QS_DT)_RAW,ID (ig_FA_AE_HF.QS_REFID1),9. NYHA Score (ig_FA_AE_HF.QS_NYHA_SCORE_C1),"10. Were any acute changes to the subjectâ€™s treatment for heart failure required to treat their acute episode of heart failure during their clinic or emergency room visit or hospitalization?<br/><br /> If Yes, complete the following:<br/> <i>Please add all changed or added medications to the Concomitant Medications eCRF</i> (ig_FA_AE_HF.TRIGGER_AC)",Escalation of chronic cardiovascular medication (not including diuretics) (ig_FA_AE_HF.TRIGGER_ECCM),Increase in oral diuretics (ig_FA_AE_HF.TRIGGER_IOD),Uptitration of IV therapy if already on therapy (ig_FA_AE_HF.TRIGGER_UIVT),"New class of medication added (e.g., beta blocker, ACE inhibitor /Angiotensin Receptor Blocker, Aldosterone receptor blocker, morphine sulfate) (ig_FA_AE_HF.TRIGGER_NCM)",Intravenous diuretics (ig_FA_AE_HF.TRIGGER_IVD),"Inotropes (e.g., dobutamine, milrinone) (ig_FA_AE_HF.TRIGGER_INOT)","Intravenous vasodilators (e.g., nitroglycerin, nitroprusside, nesiritide) (ig_FA_AE_HF.TRIGGER_IVV)","Mechanical assisted device <br /><br />If Yes, complete the following: (ig_FA_AE_HF.TRIGGER_MAD)",Indication (ig_FA_AE_HF.PR_INDICATION),Intra-aortic balloon placement (ig_FA_AE_HF.PR_OCCUR_IABP),Ventricular assist device insertion (ig_FA_AE_HF.PR_OCCUR_VADI),"Mechanical fluid removal <br /><br/>If Yes, complete the following:<br/> (ig_FA_AE_HF.TRIGGER_MFR)",Ultrafiltration (ig_FA_AE_HF.PR_OCCUR_ULTRAFIL),Hemofiltration (ig_FA_AE_HF.PR_OCCUR_HEMOFIL),Dialysis (ig_FA_AE_HF.PR_OCCUR_DIALYSIS),Other medications<br /><br /> (ig_FA_AE_HF.TRIGGER_OTH),Object of the observation (ig_FA_AE_HF.FA_OBJECT),11. Status of symptoms of heart failure at the time of discharge (ig_FA_AE_HF.FA_RES_SYMP_OUT),Lab test (ig_FA_AE_HF.LB_TEST_CD1),12. Date of BNP (B-type natriuretic peptide) at discharge (ig_FA_AE_HF.LB_SAMPLE_DT1),12. Date of BNP (B-type natriuretic peptide) at discharge (ig_FA_AE_HF.LB_SAMPLE_DT1)_RAW,13. BNP (B-type natriuretic peptide) at discharge result: (ig_FA_AE_HF.LB_RESULT1),Units (ig_FA_AE_HF.LB_RESULT1_U),Lab test (ig_FA_AE_HF.LB_TEST_CD21),14. Date of NT-pro BNP (N-terminal pro b-type natriuretic peptide) at discharge (ig_FA_AE_HF.LB_SAMPLE_DT21),14. Date of NT-pro BNP (N-terminal pro b-type natriuretic peptide) at discharge (ig_FA_AE_HF.LB_SAMPLE_DT21)_RAW,15. NT-pro BNP (N-terminal pro b-type natriuretic peptide) at discharge result: (ig_FA_AE_HF.LB_RESULT21),Units (ig_FA_AE_HF.LB_RESULT2_U),eCRF Copy Source (ig_FA_AE_HF._R_COPYSOURCE),"If modified from copy, add details into Default for this field (ig_FA_AE_HF._R_COPYMOD)",Form SDV Status,Form SDV Datetime,Form DMR Status,Form DMR Datetime,Form Frozen Status,Form Frozen Datetime,Form Locked Status,Form Locked Datetime,Form Signed Status,Form Signed Datetime
M20-371_DEV1,India,1001,SCR-0001,eg_Default1,eg_default01,1,CM/AE/SAE,ev_OMAESAE,2024-09-27,1,Heart Failure Adverse Event,FA_AE_HF,1,Submitted,2025-09-16 06:31:34 UTC,,2025-09-16 06:34:25 UTC,false,,1,2025-09-16 06:34:26 UTC,2025-09-16 07:03:08 UTC,4,0,,,2024-09-25,25-Sep-2024,72,62,mmHg,72,beats/min,34,breaths/min,101,F,38.3333333364,C,NYHA,NYHA score,2024-09-25,25-Sep-2024,1,"III - Marked limitation in activity due to symptoms, even during less-than ordinary activity. Comfortable only at rest",Yes,No,Yes,No,Yes,No,Yes,No,Yes,Heart failure,No,Yes,No,Yes,No,Yes,No,Heart failure,Partially resolved,Brain natriuretic peptide,2024-09-25,25-Sep-2024,AAAAAAAAAAAAAAAAVVVV,pg/mL,N-terminal proB-type natriuretic peptide,2024-09-25,25-Sep-2024,1111111111111FFFFFFF,pg/mL,M16-813,aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa,No,,No,,No,,No,,No,
M20-371_DEV1,India,1001,SCR-0001,UNIQUE,eg_UNIQUE,1,UNIQUE,ev_UNIQUE,2025-01-21,1,Heart Failure Adverse Event,FA_AE_HF,1,Submitted,2025-09-16 06:38:49 UTC,,2025-09-16 06:52:54 UTC,false,,1,2025-09-16 06:52:54 UTC,2025-09-16 07:03:08 UTC,5,0,,,2024-09-16,16-Sep-2024,72,72,mmHg,72,beats/min,72,breaths/min,75,F,23.8888888908,C,NYHA,,2024-09-16,16-Sep-2024,1,II - Mild symptoms and slight limitation during ordinary activity,Yes,No,Yes,No,Yes,No,Yes,No,Yes,Heart failure,No,Yes,No,Yes,No,Yes,No,Heart failure,Partially resolved,Brain natriuretic peptide,2024-09-16,16-Sep-2024,33333333333333333333,pg/mL,N-terminal proB-type natriuretic peptide,2024-09-16,16-Sep-2024,33333333333333333333,pg/mL,M16-813,aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa,No,,No,,No,,No,,No,
